Jim Cramer, the host of Mad Money, recently addressed some of the major events for Wall Street this week, focusing on earnings reports and investor days of various companies. With post-election jitters affecting the market, he warned investors to proceed with caution, as uncertainty looms over the economic landscape.

Cramer referred to Trump’s unpredictable nature, saying, “He is mercurial. Turns out he’s capricious.” Reflecting on the mood among investors, Cramer remarked that many were asking themselves, “What were we thinking?” as they processed the aftermath of the election.

He also noted the unsettling impact of Trump’s appointments to key administration positions, saying that “heads are turning” in response to some of these picks, and suggested that investors might soon feel the air leaving the post-election optimism that had initially lifted the market.

Cramer went on to caution that while there are certainly opportunities in individual stocks, especially in the wake of Trump’s policies, many stocks are still trading at levels far above where they were just a few months ago. He explained:

“Look, I’ve told you that there are many pitfalls with individual stocks when it comes to Trump 2.0. Most of them are buying opportunities but with stocks still up so much from a few months ago, you can’t be too eager to buy the dips.”

READ ALSO Jim Cramer on Microsoft and Other Stocks and Jim Cramer’s Best Performers List: Top 10 Stocks

Despite new stocks sparking interest, Cramer emphasized that he needed more time to assess market conditions before making any significant moves. He expressed a preference for waiting, stating that he doesn’t like to buy stocks only to watch them decline immediately after, a scenario he feels is likely if he rushes in too soon.

Cramer concluded by summarizing his outlook on the market, saying:

“So let me give you the bottom line: Even though the post-Trump rally hangover has been vicious, it still hasn’t taken most of the market down to levels where I think it makes sense to buy. Now, I just gave you some nuggets. I think they could be golden, but I think it’s more important to prepare yourself for better opportunities, at least in the near future.”

Our Methodology

For this article, we compiled a list of 15 stocks that were discussed by Jim Cramer during the episode of Mad Money on November 15 and listed the stocks in the order that Cramer mentioned them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Jim Cramer Is Focused on These 15 Stocks This Week

15. GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Discussing GE HealthCare Technologies Inc. (NASDAQ:GEHC), Cramer said:

“This is a stock that’s been owned by the Charitable Trust. It’s been pummeled because its former parent, GE Aerospace sold 13 million shares… and then the stock got crushed there because there were no buyers underneath. It was placed very poorly and that’s why it’s at $81. This is very strange for this incredibly high-quality medical company to fall so quickly. Now, I think they will tell a very, very good story. I think that story will resonate in part ’cause the stock’s well off its highs. That’s exactly the kind of thing that I am looking for.”

GE HealthCare (NASDAQ:GEHC) is a global leader in developing, manufacturing, and marketing a wide range of products and services aimed at supporting the diagnosis, treatment, and monitoring of patients. Management has expressed a commitment to exploring new growth opportunities and plans to elaborate on this focus during its Investor Day event, scheduled for November 21.

For the third quarter of fiscal 2024, GE HealthCare (NASDAQ:GEHC) reported mixed financial results. The company posted revenue of $4.9 billion, which fell slightly short of analysts’ expectations. However, it exceeded earnings projections, delivering an adjusted EPS of $1.14. One of the significant challenges faced by the company during this period was the impact of weaker demand in China, coupled with delays in stimulus measures, which negatively affected overall growth.

Nevertheless, the company’s focus on operational improvements paid off, as evidenced by its net income increase from $375 million to $470 million. This resulted in a rise in net income margin, which grew from 7.8% to 9.7%.

14. The Procter & Gamble Company (NYSE:PG)

Cramer said that he is looking forward to The Procter & Gamble Company’s (NYSE:PG) upcoming analyst meeting which will take place on November 21.

“The Proctor and Gamble analyst meeting. Procter does a fantastic job. Few companies explain so much to those who are thirsting for knowledge about companies themselves. Procter’s got insight in everything from China to raw costs to tariffs… I love it.”

Procter & Gamble (NYSE:PG) is a globally recognized leader in the consumer packaged goods sector. During the first quarter of the fiscal 2025 earnings call, management noted that further details on the company’s integrated strategy, which is designed to generate competitive advantages and favorable results, would be shared in greater depth at the upcoming Investor Day in November.

The company recently reported weaker-than-expected performance for the quarter, primarily due to a decline in demand from its second-largest market, Greater China. It reported adjusted earnings per share of $1.93, while revenue reached $21.74 billion. Organic sales in the region dropped by 15%, as economic factors, such as falling home prices and rising unemployment, led to reduced consumer spending. These conditions significantly impacted the sales of essential products.

Although Procter & Gamble (NYSE:PG) management remains confident in the long-term prospects of the Chinese market, they indicated that recovery in demand is unlikely to materialize in the immediate term, with a return to growth expected to take several more quarters.